AstraZeneca, a leading global pharmaceutical company, was intent on improving its marketing effectiveness while significantly reducing its costs in the face of increased cost pressures, a rapidly expanding global footprint and an increasingly diverse set of customers. It took an innovative approach to achieving its goals—including the way it managed its digital content around the globe.
This arrangement has helped AstraZeneca achieve low cost content creation and the efficient reuse and approval of content across 60 global markets and in seven different languages—English, French, German, Spanish, Italian, Chinese and Russian. Over the first three years, AstraZeneca has realized its business case, including a more than 30 percent reduction in content production costs and a 600+ percent increase in digital content availability as well as asset reuse.
Comment submitted
Submitted comment may not display automatically.